337 related articles for article (PubMed ID: 8522617)
1. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
3. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells.
Jiang H; Peterson RS; Wang W; Bartnik E; Knudson CB; Knudson W
J Biol Chem; 2002 Mar; 277(12):10531-8. PubMed ID: 11792695
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
Dougherty GJ; Cooper DL; Memory JF; Chiu RK
J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
[TBL] [Abstract][Full Text] [Related]
5. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
6. CD44H regulates tumor cell migration on hyaluronate-coated substrate.
Thomas L; Byers HR; Vink J; Stamenkovic I
J Cell Biol; 1992 Aug; 118(4):971-7. PubMed ID: 1380003
[TBL] [Abstract][Full Text] [Related]
7. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
8. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
9. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
[TBL] [Abstract][Full Text] [Related]
10. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.
Yakushijin Y; Steckel J; Kharbanda S; Hasserjian R; Neuberg D; Jiang W; Anderson I; Shipp MA
Blood; 1998 Jun; 91(11):4282-91. PubMed ID: 9596677
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44.
Chiu RK; Carpenito C; Dougherty ST; Hayes GM; Dougherty GJ
Neoplasia; 1999 Nov; 1(5):446-52. PubMed ID: 10933060
[TBL] [Abstract][Full Text] [Related]
12. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
[TBL] [Abstract][Full Text] [Related]
14. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
[TBL] [Abstract][Full Text] [Related]
15. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
16. CD44 is not an adhesive receptor for osteopontin.
Smith LL; Greenfield BW; Aruffo A; Giachelli CM
J Cell Biochem; 1999 Apr; 73(1):20-30. PubMed ID: 10088720
[TBL] [Abstract][Full Text] [Related]
17. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
Yu Q; Toole BP
J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
[TBL] [Abstract][Full Text] [Related]
18. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan.
Skelton TP; Zeng C; Nocks A; Stamenkovic I
J Cell Biol; 1998 Jan; 140(2):431-46. PubMed ID: 9442118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
